These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8162583

  • 21. Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade.
    Evans CP, Elfman F, Parangi S, Conn M, Cunha G, Shuman MA.
    Cancer Res; 1997 Aug 15; 57(16):3594-9. PubMed ID: 9270033
    [Abstract] [Full Text] [Related]

  • 22. Transfected neu oncogene induces human prostate cancer metastasis.
    Zhau HY, Zhou J, Symmans WF, Chen BQ, Chang SM, Sikes RA, Chung LW.
    Prostate; 1996 Feb 15; 28(2):73-83. PubMed ID: 8604395
    [Abstract] [Full Text] [Related]

  • 23. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.
    Shukeir N, Pakneshan P, Chen G, Szyf M, Rabbani SA.
    Cancer Res; 2006 Sep 15; 66(18):9202-10. PubMed ID: 16982764
    [Abstract] [Full Text] [Related]

  • 24. Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.
    Koutsilieris M, Reyes-Moreno C, Sourla A, Dimitriadou V, Choki I.
    Anticancer Res; 1997 Sep 15; 17(3A):1461-5. PubMed ID: 9179184
    [Abstract] [Full Text] [Related]

  • 25. Metastasis induced by overexpression of p185neu-T after orthotopic injection into a prostatic epithelial cell line (NbE).
    Marengo SR, Sikes RA, Anezinis P, Chang SM, Chung LW.
    Mol Carcinog; 1997 Jul 15; 19(3):165-75. PubMed ID: 9254883
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells.
    Mohanam S, Jasti SL, Kondraganti SR, Chandrasekar N, Kin Y, Fuller GN, Lakka SS, Kyritsis AP, Dinh DH, Olivero WC, Gujrati M, Yung WK, Rao JS.
    Clin Cancer Res; 2001 Aug 15; 7(8):2519-26. PubMed ID: 11489835
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Maspin reduces prostate cancer metastasis to bone.
    Hall DC, Johnson-Pais TL, Grubbs B, Bernal R, Leach RJ, Padalecki SS.
    Urol Oncol; 2008 Aug 15; 26(6):652-8. PubMed ID: 18367129
    [Abstract] [Full Text] [Related]

  • 30. Heparanase promotes bone destruction and invasiveness in prostate cancer.
    Zhou Y, Song B, Qin WJ, Zhang G, Zhang R, Luan Q, Pan TJ, Yang AG, Wang H.
    Cancer Lett; 2008 Sep 18; 268(2):252-9. PubMed ID: 18487013
    [Abstract] [Full Text] [Related]

  • 31. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
    Chang CJ, Ghosh PK, Hu YF, Brueggemeier RW, Lin YC.
    Res Commun Chem Pathol Pharmacol; 1993 Mar 18; 79(3):293-312. PubMed ID: 8480076
    [Abstract] [Full Text] [Related]

  • 32. Factors in prostate cancer metastasis.
    Geldof AA, Rao BR.
    Anticancer Res; 1990 Mar 18; 10(5A):1303-6. PubMed ID: 2241106
    [Abstract] [Full Text] [Related]

  • 33. Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation.
    Shain SA, Sarić T, Ke LD, Nannen D, Yoas S.
    Cell Growth Differ; 1996 May 18; 7(5):573-86. PubMed ID: 8732667
    [Abstract] [Full Text] [Related]

  • 34. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.
    Shariat SF, Roehrborn CG, McConnell JD, Park S, Alam N, Wheeler TM, Slawin KM.
    J Clin Oncol; 2007 Feb 01; 25(4):349-55. PubMed ID: 17264329
    [Abstract] [Full Text] [Related]

  • 35. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
    Nadiminty N, Lou W, Lee SO, Mehraein-Ghomi F, Kirk JS, Conroy JM, Zhang H, Gao AC.
    Clin Cancer Res; 2006 Mar 01; 12(5):1420-30. PubMed ID: 16533764
    [Abstract] [Full Text] [Related]

  • 36. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
    Krüger A, Soeltl R, Lutz V, Wilhelm OG, Magdolen V, Rojo EE, Hantzopoulos PA, Graeff H, Gänsbacher B, Schmitt M.
    Cancer Gene Ther; 2000 Feb 01; 7(2):292-9. PubMed ID: 10770639
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
    Yang J, Fizazi K, Peleg S, Sikes CR, Raymond AK, Jamal N, Hu M, Olive M, Martinez LA, Wood CG, Logothetis CJ, Karsenty G, Navone NM.
    Cancer Res; 2001 Jul 15; 61(14):5652-9. PubMed ID: 11454720
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.